2026 Christopher A. Klebanoff: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	59	3373	3106	1557	1423	123	28343

Overview

Christopher A. Klebanoff is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology.

The subfields of study within their work include Oncology, Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Genetics.

Research topics frequently addressed by Klebanoff encompass CAR-T cell therapy research, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, Monoclonal and Polyclonal Antibodies Research, T-cell and B-cell Immunology, and Virus-based gene therapy research.

The scientist has authored numerous papers, including:

Clinical implications of T cell exhaustion for cancer immunotherapy, 2022, Nature Reviews Clinical Oncology
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome, 2023, Nature Reviews Drug Discovery
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA, 2022, Nature Medicine
The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer, 2022, Immunity
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study, 2020, Clinical Cancer Research

Klebanoff frequently collaborates with several authors including Smita S. Chandran, Iñaki Etxeberría, Michael V. Gormally, Darwin Kwok, and Nicholas Stevers.

The scientist has published extensively in a variety of venues, notably Cancer Research, bioRxiv (Cold Spring Harbor Laboratory), Regular and Young Investigator Award Abstracts, Cancer Immunology Research, and Journal of Clinical Oncology.

Best Publications

Tumor mutational load predicts survival after immunotherapy across multiple cancer types.

Robert M Samstein;Chung-Han Lee;Chung-Han Lee;Alexander N Shoushtari;Alexander N Shoushtari;Matthew D Hellmann;Matthew D Hellmann

4125
Citations
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

Luca Gattinoni;Steven E. Finkelstein;Christopher A. Klebanoff;Christopher A. Klebanoff;Paul A. Antony

1247
Citations
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells

Christopher A. Klebanoff;Luca Gattinoni;Parizad Torabi-Parizi;Keith Kerstann

1231
Citations
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

Luca Gattinoni;Christopher A. Klebanoff;Christopher A. Klebanoff;Douglas C. Palmer;Claudia Wrzesinski

1199
Citations
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells

Willem W. Overwijk;Marc R. Theoret;Steven E. Finkelstein;Deborah R. Surman

1162
Citations
TOX is a critical regulator of tumour-specific T cell differentiation

Andrew C Scott;Andrew C Scott;Friederike Dündar;Paul Zumbo;Smita S Chandran

1029
Citations
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function

Madhusudhanan Sukumar;Jie Liu;Yun Ji;Murugan Subramanian

989
Citations
CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4 T helper cells and hindered by naturally occurring T regulatory cells.

Paul A. Antony;Ciriaco A. Piccirillo;Akgül Akpinarli;Steven E. Finkelstein

947
Citations
Clinical implications of T cell exhaustion for cancer immunotherapy

Unknown

872
Citations
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells

Christopher A. Klebanoff;Steven E. Finkelstein;Deborah R. Surman;Michael K. Lichtman;Michael K. Lichtman

719
Citations
Ionic immune suppression within the tumour microenvironment limits T cell effector function

Robert Eil;Suman K. Vodnala;David Clever;Christopher A. Klebanoff;Christopher A. Klebanoff

699
Citations
Paths to stemness: building the ultimate antitumour T cell

Luca Gattinoni;Christopher A. Klebanoff;Nicholas P. Restifo

690
Citations
CD8+ T‐cell memory in tumor immunology and immunotherapy

Christopher A. Klebanoff;Luca Gattinoni;Nicholas P. Restifo

663
Citations
Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels

James N. Kochenderfer;Robert P.T. Somerville;Tangying Lu;Victoria Shi

593
Citations
Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy

Christopher A. Klebanoff;Hung T. Khong;Paul A. Antony;Douglas C. Palmer

552
Citations
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy.

Christian S. Hinrichs;Rosanne Spolski;Chrystal M. Paulos;Luca Gattinoni

531
Citations
T cell stemness and dysfunction in tumors are triggered by a common mechanism.

Suman Kumar Vodnala;Robert Eil;Rigel J. Kishton;Madhusudhanan Sukumar

517
Citations
Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature

Pawel Muranski;Zachary A. Borman;Sid P. Kerkar;Christopher A. Klebanoff

516
Citations
BACH2 represses effector programs to stabilize T reg -mediated immune homeostasis

Rahul Roychoudhuri;Kiyoshi Hirahara;Kiyoshi Hirahara;Kambiz Mousavi;David Clever

470
Citations
Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Stephanie L. Goff;Mark E. Dudley;Deborah E. Citrin;Robert P. Somerville

438
Citations
Prospects for gene-engineered T cell immunotherapy for solid cancers.

Christopher A Klebanoff;Steven A Rosenberg;Nicholas P Restifo

369
Citations

Frequent Co-Authors

Nicholas P. Restifo National Institutes of Health

Luca Gattinoni University of Regensburg

Douglas C. Palmer National Institutes of Health

Zhiya Yu National Institutes of Health

Steven A. Rosenberg National Institutes of Health

James Chih-Hsin Yang National Taiwan University

David A. Scheinberg Memorial Sloan Kettering Cancer Center

Ena Wang Toro bio

Paul F. Robbins National Cancer Institute

Richard M. Siegel National Institutes of Health

External Links

Personal website of Christopher A. Klebanoff

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can offer practical career pathways. Many students begin with foundational programs like the easiest absn to get into, which provide a streamlined route into nursing while building critical patient care skills.

Nursing support roles are also vital, and enrolling in accredited lpn programs easy to get into can be a manageable entry point. These programs prepare students for hands-on roles essential to clinical environments where immunology expertise is applied.

For advanced practice, the easiest nurse practitioner program options offer a flexible route to higher responsibilities in patient diagnosis and treatment, often integrating immunology-related knowledge.

Additionally, specializing in mental health through pmhnp programs online with best clinical placement ensures excellent practical experience alongside theoretical learning, crucial for those interested in the immunological impacts of mental health disorders.

Exploring these pathways helps align your education with the dynamic field of immunology and healthcare, providing diverse opportunities to make a meaningful impact.